We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Demonstrates Latest IVD Innovations at EUROMEDLAB 2022

By Carolyn Moody, RN - News Editor
Posted on 11 Apr 2022
Print article
Image: Mindray’s total laboratory solutions ensure greater efficiency (Photo courtesy of Mindray)
Image: Mindray’s total laboratory solutions ensure greater efficiency (Photo courtesy of Mindray)

Mindray (Shenzhen, China) displayed its latest laboratory innovations at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, EUROMEDLAB 2022, in Munich, Germany. EUROMEDLAB is the most influential platform in Europe where new ideas and technologies in laboratory diagnostics are shared and showcased. Mindray’s wide range of IVD products attracted customers from Europe and other parts of the world.

At EUROMEDLAB 2022, Mindray displayed the new MC-80 automated digital cell morphology analyzer that is taking digital morphology analysis to the next level by delivering clearer images which are able to capture abnormalities in more detail. With advanced algorithms, the analyzer enables better identification of different cells with high throughput, resulting in greater productivity. Its high-performance objective and advanced image sensor offer ultra resolution images to reappear the real view under the microscope. The MC-80 has an industry-leading throughput of 60 slides per hour and features a solid rock hyper-stable anti-shake system. Aerospace materials and cutting-edge high-frequency exposure algorithm are integrated to eliminate blurred images.

Mindray also demonstrated the new CAL 8000 New Generation Cellular Analysis Line which marks the company’s expertise and innovative power in hematology area for large-scale laboratories. It has higher throughput per square meter, upgraded labXpert Data Management Software, flexible layout design options, and other advanced functionalities. Combining Mindray’s new MC-80 digital cell morphology analyzer, the CAL 8000 is taking hematology analysis automation to the next level. The touch screen is the “brain” of CAL 8000. It optimizes the distribution of workload between each analyzer unit and decides which sample requires a blood smear. It displays the status of each analyzer or SC-120 installed on CAL 8000 as well as the volume of balance reagent. This intuitive software can tell the users all necessary information of CAL 8000 at any given time. Consequently, users spend less time operating CAL 8000 and can arrange their working schedule better. Additionally, Mindray exhibited its M6000 laboratory automation system which can empower ultra high volume laboratories with high processing speed, less hands-on time, great cost efficiency and standardized analytical quality.

Related Links:
Mindray 

New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Gastrointestinal Infection Test
RIDA QUICK Cryptosporidium/Giardia/Entamoeba Combi Test
New
Toxoplasma Rapid Test
Toxo IgG/IgM Rapid Test Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.